Did My Child Inherit an Osteosarcoma Gene Mutation?

It is completely natural for parents to wonder if they passed down a “bad gene” that caused their child’s osteosarcoma. For the vast majority of families, the answer is no. The genetic changes that drive osteosarcoma are commonly randomly acquired by the bone cells during the child’s life, not inherited from a parent ^[1][2]. Even in the rare cases where a child is born with a genetic predisposition, it is often a “brand new” mutation that occurred by chance, meaning neither parent passed it down ^[3].

To understand how osteosarcoma starts, it helps to understand how cells grow and the difference between random and inherited mutations.

The Role of TP53 and RB1: The Cell’s “Brakes”

Genes act as instruction manuals for our cells. The TP53 and RB1 genes are known as tumor suppressor genes. You can think of them as the “brakes” on a car—they tell cells when to stop dividing and growing.

In osteosarcoma, these cellular brakes are commonly disrupted ^[2]. When researchers test the genetics of an osteosarcoma tumor, they often find abnormalities in the TP53 or RB1 pathways ^[1]. Without these brakes, bone cells can grow out of control and form a tumor. Osteosarcoma has very complex genetics, and many other biological factors are involved, but these two genes are frequent players. Importantly, discovering that a gene is altered in the tumor tissue does not mean the child was born with that alteration.

Somatic vs. Germline Changes

When doctors talk about genetic changes (often called pathogenic variants or mutations) in cancer, they use two specific terms that are important to distinguish:

• Somatic (Random and Acquired): These are genetic changes that happen by chance in one specific cell (like a bone precursor cell) at some point during a person’s life. They are usually found only in the tumor cells, cannot be passed down, and are not inherited. In pediatric osteosarcoma, TP53 and RB1 alterations are usually somatic ^[1][2].
• Germline (Inherited or Constitutional): These are genetic changes present in the sperm, egg, or very early embryo, meaning the child has the variant in essentially all the cells of their body. Only germline variants can be inherited from a parent or passed on to future children. Having a germline variant increases the risk of developing cancer, but it does not guarantee a tumor will form.

If a biopsy report notes a TP53 or RB1 mutation, it is usually describing the tumor itself ^[1]. A tumor-only result cannot establish or exclude inherited risk.

Reading Your Child’s Testing Reports

Note: You should always bring the exact wording of your pathology report to your oncology or genetics team. A single gene name on a report requires expert interpretation.

Inherited Syndromes and Genetic Counseling

While most osteosarcomas are not inherited, there are rare genetic syndromes caused by germline mutations that can increase a child’s risk:

• Li-Fraumeni Syndrome (LFS): This rare syndrome is caused by a germline variant in the TP53 gene. Families with LFS often have a history of multiple cancers, including bone cancer, breast cancer, and leukemia, occurring at unusually young ages ^[4].
• Hereditary Retinoblastoma: This is caused by a germline variant in the RB1 gene. Children with this variant usually develop a rare eye cancer called retinoblastoma as infants or toddlers, and have a higher risk of developing sarcomas later in life ^[5][6].

Do We Need Genetic Counseling?

A genetic counselor is a professional who interprets genetic test results, discusses who in the family may benefit from testing, and supports families through the process.

You might assume that you only need genetic counseling if you have a strong family history of young-onset cancers. However, because some inherited syndromes can appear without a family history, many pediatric oncology centers now refer children with osteosarcoma for genetic counseling regardless of their family background ^[3].

If a germline mutation is confirmed in your child, it usually does not disrupt urgent osteosarcoma treatments, but it can affect long-term care. For example, it might change how doctors monitor the child for second cancers, influence the use of radiation therapy, and determine whether parents and siblings should be offered genetic testing.

The Bottom Line: It Is Not Your Fault

Cancer genetics can be confusing, but the most important emotional takeaway is this: you did not cause your child’s cancer.

For most children, no specific cause can be identified, and there is no evidence that ordinary diet, parenting, stress, or routine pregnancy exposures caused this cancer. While prior medical radiation treatments are a known risk factor for developing secondary sarcomas later on ^[7], this is a recognized medical risk, not a parental fault.

Even among the small percentage of children who are found to have a germline TP53 mutation in their blood, one pediatric study found that nearly half of these cases were de novo variants ^[3]. A de novo variant means the genetic change happened spontaneously in the child for the very first time—it was not passed down from the mother or the father ^[3]. Parental blood tests are used to confirm if a variant is de novo.

There is nothing you did to break the “brakes” in your child’s cells. The mutations that cause osteosarcoma are random errors of biology.